Amphastar Pharmaceuticals Inc

-0.26 (-1.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)948.60M
Current PE619.60
Forward PE 20.13
2yr Forward PE 14.48
See more stats
Estimates Current Quarter
Revenue$101.72 Million
Adjusted EPS$0.21
See more estimates
10-Day MA$19.88
50-Day MA$18.69
200-Day MA$18.94
See more pivots

Amphastar Pharmaceuticals Inc Stock, NASDAQ:AMPH

11570 6th Street, Rancho Cucamonga, California 91730
Phone: +1.909.980.9484
Number of Employees: 1980


Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.